Related Experiment Videos
[Skin ulcers in rheumatoid arthritis]
M Walchner1, G Messer, M Meurer
1Dermatologische Klinik und Poliklinik, Ludwig-Maximilians-Universität München.
Summary
Severe skin ulcers in rheumatoid arthritis patients indicate disease progression and increased mortality. Management involves autoimmune disease stabilization, pain relief, and surgical intervention, with immunotherapy offering future hope.
Area of Science:
- Rheumatology
- Dermatology
- Immunology
Background:
- Severe skin ulceration in rheumatoid arthritis (RA) is linked to disease progression, internal organ involvement, and mortality.
- Pathogenesis involves immune complex vasculitis, anti-inflammatory drug side effects, vascular insufficiency, and mechanical factors.
Observation:
- Ulcers in RA patients often exhibit poor healing due to multifactorial causes.
- Management requires addressing the underlying autoimmune condition and local ulcer factors.
Findings:
- Systemic treatment includes glucocorticosteroids, immunosuppressants, or plasmapheresis to stabilize RA.
- Adjuvant therapies comprise analgesics, improved perfusion, and anti-inflammatory drugs alongside topical treatments.
- Surgical intervention, preferably vascularized muscle flaps, is often necessary for extensive ulceration.
Implications:
- Effective management of RA-associated ulcers requires a multi-pronged approach.
- Vascularized muscle flaps are superior to grafts for extensive ulcer repair.
- Immunotherapy with monoclonal antibodies presents a promising future treatment avenue for severe RA ulceration.